title: Impact of statin use on oncologic outcomes of patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
authors.forename: Evanguelos
authors.initials: E
authors.lastname: Xylinas
authors.forename: Luis A
authors.initials: LA
authors.lastname: Kluth
authors.forename: Joseph J
authors.initials: JJ
authors.lastname: Crivelli
authors.forename: Malte
authors.initials: M
authors.lastname: Rieken
authors.forename: Vitaly
authors.initials: V
authors.lastname: Margulis
authors.forename: Christian
authors.initials: C
authors.lastname: Seitz
authors.forename: Shahrokh F
authors.initials: SF
authors.lastname: Shariat
mesh_terms: D002295:Carcinoma, Transitional Cell / Q000150:complications / Q000401:mortality / Q000601:surgery*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy*; D007680:Kidney Neoplasms / Q000150:complications / Q000401:mortality / Q000601:surgery*; D007682:Kidney Pelvis; D008297:Male; D009392:Nephrectomy; D016016:Proportional Hazards Models; D012189:Retrospective Studies; D016896:Treatment Outcome; D014513:Ureter / Q000601:surgery; D014516:Ureteral Neoplasms / Q000150:complications / Q000401:mortality / Q000601:surgery*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors